In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Orion Corp.

Latest From Orion Corp.

ASCO 2020: Can Xtandi PROSPER In Prostate OS Data Battle?

While Xtandi has positive new survival data in prostate cancer, other rivals in the competitive market are reporting the same at ASCO.

ASCO Clinical Trials

New Drug Launches Worldwide Dipped In 2019

The number of new active substances launched in their first market in 2019 dropped as 2018’s superlative performance gave way to something more usual.

Companies Innovation

Can Zydus Cadila's Cut-Price Enzalutamide Shake Up Indian Market?

Cadila Healthcare has launched a generic version of Astellas/Pfizer’s prostate cancer therapy Xtandi in India at a sharp discount of 70-90% to existing brands and hopes the lower financial burden on patients will aid adherence.

Commercial Business Strategies

Orion Pragmatic After First-Quarter COVID-19 Impact

Buoyed by strong demand caused by COVID-19 induced stockpiling, including for its range of generic products, Finland’s Orion enjoyed double-digit growth in the first quarter. However, this trend will ease off through the year, the company says.

Sales & Earnings Strategy
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
    • Generic Drugs
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Finland
  • Parent & Subsidiaries
  • Orion Corp.
  • Senior Management
  • Timo Lappalainen , Pres., CEO & Chmn.
    Jari Karlson, CFO
    Satu Ahomaki, SVP, Commercial Operations
    Christer Nordstedt, MD, PhD, SVP, R&D
  • Contact Info
  • Orion Corp.
    Phone: (358) 10 4261
    Orionintie 1A 02200
    P.O. Box 65 Espoo, 02101